Telegram
Facebook
Twitter
ВКонтакте
Telegram
Сообщить о неточностиIntellia Therapeutics Мультипликаторы 2011-2024 | NTLA
Мультипликаторы по годам Intellia Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-5.1 | -6.3 | -25.0 | -26.1 | -1.2 | -6.9 | -13.8 | -8.8 | - | - | - | - | - |
P/S |
67.1 | 57.3 | 202.8 | 60.5 | 13.1 | 19.5 | 35.8 | 16.9 | - | - | - | - | - |
EPS |
-5.4 | -6.2 | -3.8 | -2.4 | -2.1 | -2.0 | -1.9 | -1.4 | -51.0 | - | - | - | - |
EV (Enterprise Value) |
2.46 млрд | 2.75 млрд | 6.58 млрд | 3.35 млрд | 505 млн | 603 млн | 670 млн | 95.2 млн | -61 млн | -6.72 млн | - | - | - |
EBITDA per Share |
-5.7 | -5.85 | -3.68 | -2.33 | -2.13 | -2.01 | -1.85 | -1.4 | - | - | - | - | - |
EV/EBITDA |
0.4 | -25.7 | -5.3 | -6.2 | -8.9 | -0.2 | - | - | - | - | - | ||
PEG |
-0.19 | -0.22 | -1.09 | 1.9 | 0.91 | 1.31 | 0.43 | 0.09 | - | - | - | - | - |
P/B |
2.3 | 2.4 | 5.2 | 5.2 | 1.7 | 2.1 | 3.1 | 1.3 | - | - | - | - | - |
P/CF |
-6.2 | -9.0 | -29.8 | -70.2 | -5.5 | -8.8 | -12.4 | 9.3 | - | - | - | - | - |
ROE % |
-45.82 | -38.38 | -25.75 | -25.47 | -175.70 | -30.71 | -22.47 | -15.08 | - | - | - | - | - |
ROA % |
-36.99 | -31.19 | -20.70 | -19.85 | -141.85 | -24.57 | -17.95 | -10.58 | - | - | - | - | - |
ROCE % |
-49.07 | -37.08 | -25.75 | -25.91 | -39.41 | -29.62 | -20.17 | -11.99 | - | - | - | - | - |
Current Ratio |
5.2 | 5.3 | - | - | - | 8.0 | 11.3 | 9.2 | - | - | - | - | - |
DSO |
202.4 | 20.3 | 23.0 | 21.2 | 51.5 | 90.5 | 146.3 | 143.0 | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
202.4 | 20.3 | 23.0 | 21.2 | 51.5 | - | - | - | - | - | - | - | - |
Финансовый цикл |
202.4 | 20.3 | 23.0 | 21.2 | 51.5 | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD
Мультипликаторы поквартально Intellia Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-1.38 | -1.4 | -1.17 | - | -1.49 | -1.33 | -1.96 | - | -0.97 | -1.01 | -0.69 | -0.69 | -0.47 | -0.61 | -0.63 | -0.57 | -0.49 | -0.56 | -0.49 | -0.43 | -0.53 | -0.52 | -0.51 | -0.61 | -0.44 | -0.45 | -0.36 | -0.31 | -0.22 | -0.36 | -9.89 | -9.57 | -10.27 | -2.37 | -0.85 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA per Share |
- | - | -1.25 | - | -1.31 | -1.3 | -1.91 | - | -0.91 | -1.01 | -0.67 | -0.69 | -0.4 | -0.56 | -0.62 | -0.6 | -0.44 | -0.54 | -0.5 | -0.47 | -0.48 | -0.5 | -0.51 | -0.63 | -0.39 | -0.42 | -0.35 | -0.31 | -0.2 | -0.34 | -9.63 | -10 | -10.6 | -2.59 | -0.9 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROE % |
-45.36 | -47.30 | -47.54 | -40.56 | -47.03 | -39.78 | -42.25 | -28.84 | -36.85 | -35.66 | -27.90 | -25.47 | -27.94 | -31.41 | -34.79 | -36.88 | -33.26 | -32.67 | -31.15 | -30.71 | -31.82 | -28.76 | -25.95 | -22.47 | -19.53 | -17.99 | -16.09 | -15.08 | 14.70 | 32.50 | 50.13 | 58.47 | 33.73 | 19.49 | 5.16 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROA % |
-36.89 | -37.50 | -40.37 | -34.86 | -40.23 | -22.94 | -33.18 | -22.05 | -28.29 | -27.04 | -21.59 | -19.85 | -22.07 | -25.02 | -27.91 | -29.78 | -26.81 | -26.27 | -24.99 | -24.57 | -25.45 | -23.00 | -20.74 | -17.95 | -15.12 | -13.54 | -11.70 | -10.58 | -13.43 | -14.61 | -16.00 | -15.09 | -8.71 | -5.03 | -1.33 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
ROCE % |
-46.81 | -46.96 | -46.15 | -39.08 | -45.58 | -39.29 | -42.08 | -28.96 | -37.00 | -35.83 | -28.15 | -25.91 | -28.90 | -32.95 | -36.86 | -39.41 | -35.85 | -35.13 | -33.45 | -32.70 | -33.45 | -30.06 | -26.90 | -23.14 | -20.07 | -18.46 | -16.44 | -15.33 | 15.73 | 34.97 | 54.42 | 63.25 | 37.35 | 21.78 | 5.64 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
6.0 | - | - | 5.3 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DSO |
43.9 | 33.4 | 31.4 | - | 23.6 | 15.1 | 15.5 | - | 28.4 | 20.5 | 21.8 | 29.5 | 8.8 | 11.9 | 23.8 | 38.5 | 39.7 | 37.9 | 53.2 | 87.4 | 93.0 | 89.7 | 110.1 | 143.3 | 130.6 | 161.5 | 124.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Операционный цикл |
43.9 | 33.4 | 31.4 | - | 23.6 | 15.1 | 15.5 | - | 28.4 | 20.5 | 21.8 | 29.5 | 8.8 | 11.9 | 23.8 | 38.5 | 39.7 | 37.9 | 53.2 | 87.4 | 93.0 | 89.7 | 110.1 | 143.3 | 130.6 | 161.5 | 124.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Финансовый цикл |
43.9 | 33.4 | 31.4 | - | 23.6 | 15.1 | 15.5 | - | 28.4 | 20.5 | 21.8 | 29.5 | 8.8 | 11.9 | 23.8 | 38.5 | 39.7 | 37.9 | 53.2 | 87.4 | 93.0 | 89.7 | 110.1 | 143.3 | 130.6 | 161.5 | 124.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Все данные представлены в валюте USD